Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Artiva Biotherapeutics Inc’s current trading price is -90.29% away from its 52-week high, while its distance from the 52-week low is -5.62%. The stock’s price range over this period has fluctuated between $1.78 and $17.31. The company, operating within the financial sector, had a trading volume of approximately 0.32 million for the day, which was noticeably higher than the average daily share volume of 0.32 million over the last 3 months.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Artiva Biotherapeutics Inc (ARTV) has experienced a quarterly decline of -62.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 40.93M and boasts a workforce of 89 employees.
Analyzing Trading Volume and Moving Average Trends
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ARTV stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.06.
ARTV Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price decrease of -83.33%. However, over the past six months, we’ve seen a stronger performance of -84.18%. The price of ARTV leaped by -16.83% over the last 30 days. And in the last five days, it has fallen by -14.29%.
